Table 3.
Female |
Male |
|||
---|---|---|---|---|
Placebo | Naltrexone | Placebo | Naltrexone | |
CPT tolerance (s) | ||||
Rest | 55.1 (9.4) | 57.5 (9.4) | 78.0 (7.4) | 79.6 (7.5) |
Stress | 64.2 (11.4) | 60.2 (9.8) | 89.6 (9.0) | 80.9 (7.8) |
CPT MPQ-total | ||||
Rest | 17.2 (1.4) | 19.0 (1.6) | 14.1 (1.1) | 13.6 (1.2) |
Stress | 17.6 (1.3) | 18.2 (1.4) | 13.6 (1.0) | 13.8 (1.1) |
Heat pain threshold (°C) | ||||
Rest | 43.4 (0.6) | 42.7 (0.6) | 43.7 (0.5) | 43.6 (0.5) |
Stress | 43.0 (0.6) | 43.2 (0.6) | 44.3 (0.4) | 43.8 (0.5) |
Heat pain tolerance (°C) | ||||
Rest | 48.0 (0.4) | 47.8 (0.4) | 49.1 (0.3) | 49.0 (0.3) |
Stress | 47.9 (0.4) | 48.2 (0.4) | 49.3 (0.3) | 49.1 (0.3) |
Heat pain MPQ-total | ||||
Rest | 19.0 (1.3) | 18.9 (1.3) | 15.3 (1.0) | 15.2 (1.0) |
Stress | 17.8 (2.1) | 19.6 (1.3) | 17.4 (1.6) | 14.9 (1.0) |
Entries show mean and the standard error of the mean that are adjusted for smoking status and the order of task